JPH10316573A5 - - Google Patents

Info

Publication number
JPH10316573A5
JPH10316573A5 JP1998112312A JP11231298A JPH10316573A5 JP H10316573 A5 JPH10316573 A5 JP H10316573A5 JP 1998112312 A JP1998112312 A JP 1998112312A JP 11231298 A JP11231298 A JP 11231298A JP H10316573 A5 JPH10316573 A5 JP H10316573A5
Authority
JP
Japan
Prior art keywords
dosage unit
carrier
starch
weight
unit according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1998112312A
Other languages
English (en)
Japanese (ja)
Other versions
JPH10316573A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JPH10316573A publication Critical patent/JPH10316573A/ja
Publication of JPH10316573A5 publication Critical patent/JPH10316573A5/ja
Pending legal-status Critical Current

Links

JP10112312A 1997-04-22 1998-04-22 製薬投与単位体 Pending JPH10316573A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL97201180.3 1997-04-22
EP97201180 1997-04-22

Publications (2)

Publication Number Publication Date
JPH10316573A JPH10316573A (ja) 1998-12-02
JPH10316573A5 true JPH10316573A5 (https=) 2005-09-22

Family

ID=8228228

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10112312A Pending JPH10316573A (ja) 1997-04-22 1998-04-22 製薬投与単位体

Country Status (25)

Country Link
US (6) US6399594B2 (https=)
EP (1) EP0975348B1 (https=)
JP (1) JPH10316573A (https=)
KR (1) KR100580855B1 (https=)
CN (2) CN1494908A (https=)
AR (1) AR012480A1 (https=)
AT (1) ATE281836T1 (https=)
AU (1) AU742037B2 (https=)
BR (1) BR9809268A (https=)
CA (1) CA2288070A1 (https=)
DE (1) DE69827484T2 (https=)
DK (1) DK0975348T3 (https=)
ES (1) ES2232949T3 (https=)
HU (1) HUP0001780A3 (https=)
ID (1) ID22763A (https=)
IL (1) IL123984A (https=)
NO (1) NO995127D0 (https=)
NZ (1) NZ338028A (https=)
PL (1) PL190227B1 (https=)
PT (1) PT975348E (https=)
RU (1) RU2207133C2 (https=)
TR (1) TR199902530T2 (https=)
TW (1) TW570798B (https=)
WO (1) WO1998047517A1 (https=)
ZA (1) ZA983169B (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1121375B1 (en) * 1998-10-16 2003-05-02 Akzo Nobel N.V. High purity compound (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one
ES2316350T3 (es) * 1999-02-26 2009-04-16 SHIONOGI & CO., LTD. Capsulas blandas masticables con propiedades mejoradas de administracion y procedimiento para producirlas.
US20040229854A1 (en) * 2000-11-28 2004-11-18 Pieter Haan De Immediate release dosage form for HRT
US20070098784A1 (en) 2001-09-28 2007-05-03 Nutraceutix, Inc. Delivery system for biological component
DK1429802T3 (da) * 2001-09-28 2013-02-18 Tntgamble Inc Tilførselssystem for biologisk komponent
GB0125061D0 (en) * 2001-10-18 2001-12-12 Norton Healthcare Ltd Pharmaceutical composition
TW200418525A (en) * 2002-11-20 2004-10-01 Akzo Nobel Nv Coated pharmaceutical tablets containing Tibolone
CN1324041C (zh) * 2003-04-01 2007-07-04 上海迪赛诺医药科技开发有限公司 替勃龙晶型i的制备方法
BRPI0409860A (pt) * 2003-04-29 2006-05-16 Akzo Nobel Nv processo de solidificação anti-solvente
JP2006514996A (ja) * 2003-05-23 2006-05-18 アクゾ・ノベル・エヌ・ベー 多形性チボロンを含有する即時放出性薬物剤形
EP1742615A2 (en) * 2004-05-05 2007-01-17 Akzo Nobel N.V. Antisolvent emulsion solidification process
WO2005117899A1 (en) * 2004-06-02 2005-12-15 Cipla Limited Pharmaceutical composition comprising tibolone and process for procuding the same
WO2005120517A1 (en) * 2004-06-07 2005-12-22 Strides Arcolab Limited Stable liquid suspension formulation comprising synthetic steroids and process for producing the same
CZ300465B6 (cs) * 2007-07-25 2009-05-27 Zentiva, A. S. Zpusob výroby komprimované farmaceutické formulace s obsahem tibolonu
CN102085193B (zh) * 2009-12-08 2013-11-06 北京以岭生物工程技术有限公司 一种替勃龙口腔崩解片及其制备方法
CN104345098B (zh) * 2013-08-05 2016-04-13 华润紫竹药业有限公司 一种测定替勃龙片剂中抗氧剂含量的方法
MX381207B (es) 2016-05-04 2025-03-12 Novalon S A Uso de alcoholes de azucar en composiciones de tibolona

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4701450A (en) 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators
CH676470A5 (https=) * 1988-02-03 1991-01-31 Nestle Sa
IE63051B1 (en) * 1989-03-18 1995-03-22 Akzo Nv Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one
ES2134313T3 (es) * 1993-03-05 1999-10-01 Akzo Nobel Nv Utilizacion de derivados de pregnano para el tratamiento de tumores.
AU7719894A (en) * 1993-09-03 1995-03-22 Smithkline Beecham Corporation Stabilized tablet formulation
IL115445A (en) * 1994-10-17 1999-08-17 Akzo Nobel Nv Solid pharmaceutical compositions comprising low dosage active ingredient oil and excipient capable of binding water and their preparation

Similar Documents

Publication Publication Date Title
JPH10316573A5 (https=)
US5380535A (en) Chewable drug-delivery compositions and methods for preparing the same
US5320848A (en) Chewable drug-delivery composition
RU99121407A (ru) Стабилизированные композиции тиболона
DE69915718D1 (de) Fliessfähige, direktverpressbare Stärke als Bindemittel, Sprengmittel und Füllstoff für Presstabletten und Hartgelatinkapseln
DE60008912D1 (de) Direktverpressbare, ultrafeine acetaminophenzusammensetzungen und verfahren zu ihrer herstellung
JP2006514100A5 (https=)
RU96118271A (ru) Композиции, содержащие тонкоизмельченный небиволол
EP2417977A1 (en) Calcium carbonate granulation
AU742037B2 (en) Stabilized tibolone compositions
ZA200510224B (en) Pharmaceutical formulation comprising levothyroxine sodium
Te Wierik et al. A new generation starch product as excipient in pharmaceutical tablets: III. Parameters affecting controlled drug release from tablets based on high surface area retrograded pregelatinized potato starch
US5198228A (en) Direct dry compressible acetaminophen tablet
US5037658A (en) Direct dry compressible acetaminophen composition
ES2206129T5 (es) Composicion que comprende acido ascorbico como componente principal y pectina.
PT1546067E (pt) Composição fumígena
JPH08157362A (ja) 油性物質含有固形製剤の製法
JP2016041662A (ja) 速崩壊錠剤
RU96105027A (ru) Новое лекарственное средство для перорального введения, включающее прогестерон и полиэтиленгликоль совместно с наполнителем
JP7080215B2 (ja) 顆粒製剤
KR920700658A (ko) 칼륨 보충을 위한 약학 조성물
Tanaka et al. Effect of DV-7028, a new 5-HT2 receptor antagonist, on cyclic blood flow reduction in the canine coronary artery.
CN121360090A (zh) 一种孟鲁司特钠咀嚼片及其制备方法和应用
CN116139128A (zh) 一种依折麦布和吉非贝齐的复方制剂
RU99117383A (ru) Композиционный состав антиаритмического лекарственного средства